Culture of human bone marrow CD34~+ stem cells and differentiation induced by vascular endothelial growth factor 165

Li Xiao-wen,Tian Ying-hong
2009-01-01
Abstract:BACKGROUND: CD34+ stem cells in bone marrow can differentiate into endothelial cells under a certain condition. OBJECTIVE: To in vitro separate, purify and culture human marrow CD34+ hematopoietic stem cells, and to detect their immunophenotypes and to investigate the changes in cell immunophenotype after in vitro differentiation by vascular endothelial growth factor (VEGF) transfectant. DESIGN, TIME AND SETTING: The cytology observation experiment was performed at the Institute of Neurobiology, Southern Medical University from October 2005 to October 2007. MATERIALS: The bone marrow was obtained from healthy donors. METHODS: CD34+ stem cells were separated, cultured and proliferated by Percoll gradient centrifugation, adherence screening method and monoclonal culture. Well growth passaged cells were collected by liposome-mediated infection protocol. VEGF165 gene was used to transfect human bone marrow CD34+ stem cells. MAIN OUTCOME MEASURES: Immunophenotypes of CD34+ stem cells were detected by immunofluorescence and flow cytometry. Cell immunophenotype changes and VEGF secretion were detected following VEGF156 gene transfection. RESULTS: High homogenous CD34+ stem cells had been isolated and cultured in vitro, and the morphous was like fibroblast. CD34+ stem cells had unique immunophenotypes and they were positive for CD44, CD29 and c-kit, but negative for CD31 and CD54. After VEGF-165 transfection, CD34+ stem cells presented endothelial differentiation with the expression of CD44 decrease and CD31 increase, as well as could secrete a large number of VEGF. CONCLUSION: High homogenous CD34+ stem cells had been isolated and cultured by Percoll isolation method, adherence screening method and monoclonal culture. VEGF-165 transfectant can induce CD34+ stem cells to differentiate towards endothelial cells.
What problem does this paper attempt to address?